Endothelial cell tolerance to lipopolysaccharide challenge is induced by monophosphoryl lipid A

Clinical Science

Volumn 130, Issue 6, 2016, Pages 451-461

  Stark, Ryan J ^a   Choi, Hyehun ^a   Koch, Stephen R ^a   Fensterheim, Benjamin A ^b   Lamb, Fred S ^a   Sherwood, Edward R ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial cells; Endotoxin; Monophosphoryl lipid A; Tolerance; Toll like receptor 4

Indexed keywords

I KAPPA B KINASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHORYL LIPID A; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TOLL LIKE RECEPTOR AFFECTING AGENT; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK3 PROTEIN, HUMAN; LIPID A; MYD88 PROTEIN, HUMAN; TICAM1 PROTEIN, HUMAN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROVOCATION TEST; SIGNAL TRANSDUCTION; SUPERNATANT; UMBILICAL VEIN ENDOTHELIAL CELL; ANALOGS AND DERIVATIVES; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ADJUVANTS, IMMUNOLOGIC; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LIPID A; LIPOPOLYSACCHARIDES; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHORYLATION;

EID: 84958063963     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20150592     Document Type: Article

References (35)

1. Aird, W.C. (2003) The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101, 3765-3777
2. Pober, J.S. and Sessa, W.C. (2007) Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7, 803-815
3. Draisma, A., Pickkers, P., Bouw, M.P. and van der Hoeven, J.G. (2009) Development of endotoxin tolerance in humans in vivo. Crit. Care Med. 37, 1261-1267
4. Greisman, S.E., Young, E.J. and Carozza, Jr, F.A. (1969) Mechanisms of endotoxin tolerance. V. Specificity of the early and late phases of pyrogenic tolerance. J. Immunol. 103, 1223-1236
5. Madonna, G.S. and Vogel, S.N. (1985) Early endotoxin tolerance is associated with alterations in bone marrow-derived macrophage precursor pools. J. Immunol. 135, 3763-3771
6. Mages, J., Dietrich, H. and Lang, R. (2007) A genome-wide analysis of LPS tolerance in macrophages. Immunobiology 212, 723-737
7. Cavaillon, J.M. and Adib-Conquy, M. (2006) Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit. Care 10, 233
8. Wang, W., Deng, M., Liu, X., Ai, W., Tang, Q. and Hu, J. (2011) TLR4 activation induces nontolerant inflammatory response in endothelial cells. Inflammation 34, 509-518
9. Ogawa, H., Rafiee, P., Heidemann, J., Fisher, P.J., Johnson, N.A., Otterson, M.F., Kalyanaraman, B., Pritchard, Jr, K.A. and Binion, D.G. (2003) Mechanisms of endotoxin tolerance in human intestinal microvascular endothelial cells. J. Immunol. 170, 5956-5964
10. van't Veer, C., van den Pangaart, P.S., van Zoelen, M.A., de Kruif, M., Birjmohun, R.S., Stroes, E.S., de Vos, A.F. and van der Poll, T. (2007) Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J. Immunol. +179, 7110-7120
11. Chang, E.Y., Guo, B., Doyle, S.E. and Cheng, G. (2007) Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production. J. Immunol. +178, 6705-6709
12. Biswas, S.K., Bist, P., Dhillon, M.K., Kajiji, T., Del Fresno, C., Yamamoto, M., Lopez-Collazo, E., Akira, S. and Tergaonkar, V. (2007) Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance. J. Immunol. +179, 4083-4092
13. Covert, M.W., Leung, T.H., Gaston, J.E. and Baltimore, D. (2005) Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science +309, 1854-1857
14. Wang, Y., Yang, Y., Liu, X., Wang, N., Cao, H., Lu, Y., Zhou, H. and Zheng, J. (2012) Inhibition of clathrin/dynamin-dependent internalization interferes with LPS-mediated TRAM-TRIF-dependent signaling pathway. Cell Immunol. 274, 121-129
15. Andreakos, E., Sacre, S.M., Smith, C., Lundberg, A., Kiriakidis, S., Stonehouse, T., Monaco, C., Feldmann, M. and Foxwell, B.M. (2004) Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. Blood 103, 2229-2237
16. Stark, R., Choi, H., Koch, S., Lamb, F. and Sherwood, E. (2015) Monophosphoryl lipid A inhibits the cytokine response of endothelial cells challenged with LPS. Innate Immun. 21, 565-574
17. Casella, C.R. and Mitchell, T.C. (2008) Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell Mol. Life Sci. 65, 3231-3240
18. Romero, C.D., Varma, T.K., Hobbs, J.B., Reyes, A., Driver, B. and Sherwood, E.R. (2011) The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection. Infect. Immun. 79, 3576-3587
19. Mata-Haro, V., Cekic, C., Martin, M., Chilton, P.M., Casella, C.R. and Mitchell, T.C. (2007) The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 316, 1628-1632
20. Marsh, B., Stevens, S.L., Packard, A.E., Gopalan, B., Hunter, B., Leung, P.Y., Harrington, C.A. and Stenzel-Poore, M.P. (2009) Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. J. Neurosci. 29, 9839-9849
21. Cargnello, M. and Roux, P.P. (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. Biol. Rev. +75, 50-83
22. Kraatz, J., Clair, L., Rodriguez, J.L. and West, M.A. (1999) Macrophage TNF secretion in endotoxin tolerance: role of SAPK, p38, and MAPK. J. Surg. Res. +83, 158-164
23. Piao, W., Song, C., Chen, H., Diaz, M.A., Wahl, L.M., Fitzgerald, K.A., Li, L. and Medvedev, A.E. (2009) Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling. J. Leukoc. Biol. 86, 863-875
24. Elliott, G.T. (1998) Monophosphoryl lipid A induces delayed preconditioning against cardiac ischemia-reperfusion injury. J. Mol. Cell Cardiol. 30, 3-17
25. Peng, J., Lu, R., Deng, H.W. and Li, Y.J. (2002) Involvement of alpha-calcitonin gene-related peptide in monophosphoryl lipid A-induced delayed preconditioning in rat hearts. Eur. J. Pharmacol. +436, 89-96
26. Cavaillon, J.M., Adrie, C., Fitting, C. and Adib-Conquy, M. (2003) Endotoxin tolerance: is there a clinical relevance? J. Endotoxin. Res. 9, 101-107
27. Wheeler, D.S., Lahni, P.M., Denenberg, A.G., Poynter, S.E., Wong, H.R., Cook, J.A. and Zingarelli, B. (2008) Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis. Shock 30, 267-273
28. Lundberg, A.M., Drexler, S.K., Monaco, C., Williams, L.M., Sacre, S.M., Feldmann, M. and Foxwell, B.M. (2007) Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems. Blood 110, 3245-3252
29. Kagan, J.C., Su, T., Horng, T., Chow, A., Akira, S. and Medzhitov, R. (2008) TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. +9, 361-368
30. Husebye, H., Aune, M.H., Stenvik, J., Samstad, E., Skjeldal, F., Halaas, O., Nilsen, N.J., Stenmark, H., Latz, E., Lien, E. et al. (2010) The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. Immunity 33, 583-596
31. Biswas, S.K. and Lopez-Collazo, E. (2009) Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30, 475-487
32. Maeng, Y.S., Min, J.K., Kim, J.H., Yamagishi, A., Mochizuki, N., Kwon, J.Y., Park, Y.W., Kim, Y.M. and Kwon, Y.G. (2006) ERK is an anti-inflammatory signal that suppresses expression of NF-kappaB-dependent inflammatory genes by inhibiting IKK activity in endothelial cells. Cell Signal. 18, 994-1005
33. Jin, J.O., Zhang, W., Wong, K.W., Kwak, M., van Driel, I.R. and Yu, Q. (2014) Inhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulation. PLoS One 9, e104753
34. Robbins, M., Judge, A. and MacLachlan, I. (2009) siRNA and innate immunity. Oligonucleotides +19, 89-102
35. Castegren, M., Skorup, P., Lipcsey, M., Larsson, A. and Sjolin, J. (2013) Endotoxin tolerance variation over 24 h during porcine endotoxemia: association with changes in circulation and organ dysfunction. PLoS One 8, e53221